| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |